⌘K

Login Start Free

RESMED INC·4

Jul 2, 5:53 PM ET

Sandercock Brett 4

4 · RESMED INC · Filed Jul 2, 2025

Insider Transaction Report

Form 4

Period: 2025-07-01

Sandercock Brett

Chief Financial Officer

Transactions

Sale
ResMed Common Stock
2025-07-01$256.99/sh−3,883$997,892→ 84,283 total
Exercise/Conversion
ResMed Common Stock
2025-07-01$101.64/sh+917$93,204→ 88,166 total
Exercise/Conversion
ResMed Common Stock Options
2025-07-01−1,966→ 8,917 total
Exercise: $101.64From: 2019-11-11Exp: 2025-11-14→ ResMed Common Stock (1,966 underlying)
Exercise/Conversion
ResMed Common Stock Options
2025-07-01−917→ 8,000 total
Exercise: $101.64From: 2019-11-11Exp: 2025-11-14→ ResMed Common Stock (917 underlying)
Exercise/Conversion
ResMed Common Stock
2025-07-01$101.64/sh+1,966$199,824→ 87,249 total

Footnotes (2)

[F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
[F2]Represents date options first become exercisable. Options vest 1/3 per year.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT